This study was subsequently reported by Asuthkar's team, which further found that the overexpression of miR-29 in MYC+ medulloblastoma cells mediated the downregulation of B7-H3 and inhibited angiogenesis in medulloblastoma. The gene discussed is CD276; the disease is medulloblastoma.